ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMTI Applied Molecular Transport Inc

0.263
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.263
Ask Price 0.263
News -
Day High

Low
0.1343

52 Week Range

High
0.4893

Day Low
Share Name Share Symbol Market Stock Type
Applied Molecular Transport Inc AMTI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.263 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.263
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.1343 - 0.4893
Last Trade Type Quantity Price Currency
- 0 US$ 0.263 USD

Applied Molecular Transport Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 10.87M - - - -48.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Applied Molecular Transp... News

Date Time Source News Article
1/09/202405:12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section..
1/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
1/02/202408:15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf..
1/02/202408:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in..
12/28/202316:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/27/202315:15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied..
12/27/202314:49Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMTI Message Board. Create One! See More Posts on AMTI Message Board See More Message Board Posts

Historical AMTI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.1840.320.13430.1780009357,1360.07942.93%
1 Year0.3410.48930.13430.2216842552,106-0.078-22.87%
3 Years49.1068.140.13438.16354,551-48.84-99.46%
5 Years18.0678.220.134311.84322,490-17.80-98.54%

Applied Molecular Transp... Description

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

Your Recent History

Delayed Upgrade Clock